A microphysiological system reveals neutrophil contact-dependent attenuation of pancreatic tumor progression by CXCR2 inhibition-based immunotherapy
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
A microphysiological system reveals neutrophil contact-dependent attenuation of pancreatic tumor progression by CXCR2 inhibition-based immunotherapy ; volume:14 ; number:1 ; day:19 ; month:6 ; year:2024 ; pages:1-16 ; date:12.2024
Scientific reports ; 14, Heft 1 (19.6.2024), 1-16, 12.2024
- Creator
-
Shao, Shuai
Delk, Nikki A.
Jones, Caroline N.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-024-64780-4
- URN
-
urn:nbn:de:101:1-2409102103043.056534941521
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:20 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Shao, Shuai
- Delk, Nikki A.
- Jones, Caroline N.
- SpringerLink (Online service)
Other Objects (12)
Clinical immunotherapy in pancreatic cancer
Role of Pancreatic Attenuation Index in Assessing Pancreatic Fat Content and Postpancreatectomy Outcomes
Barriers and opportunities in pancreatic cancer immunotherapy
Lipocalin-2 and neutrophil activation in pancreatic cancer cachexia
Neutrophil to lymphocyte ratio predicts prognosis in unresectable pancreatic cancer
Acquired resistance to immunotherapy in MMR-D pancreatic cancer
RNAi-Mediated PD-L1 Inhibition for Pancreatic Cancer Immunotherapy
Hypoxia as a barrier to immunotherapy in pancreatic adenocarcinoma
Challenges and Future Perspectives of Immunotherapy in Pancreatic Cancer
Attenuation of hedgehog/GLI signaling by NT1721 extends survival in pancreatic cancer
Chemokine CCL21 determines immunotherapy response in hepatocellular carcinoma by affecting neutrophil polarization
Neutrophil Camouflaged Stealth Nanovehicle for Photothermal‐Induced Tumor Immunotherapy by Triggering Pyroptosis
Clinical immunotherapy in pancreatic cancer
Role of Pancreatic Attenuation Index in Assessing Pancreatic Fat Content and Postpancreatectomy Outcomes
Barriers and opportunities in pancreatic cancer immunotherapy
Lipocalin-2 and neutrophil activation in pancreatic cancer cachexia
Neutrophil to lymphocyte ratio predicts prognosis in unresectable pancreatic cancer
Acquired resistance to immunotherapy in MMR-D pancreatic cancer
RNAi-Mediated PD-L1 Inhibition for Pancreatic Cancer Immunotherapy
Hypoxia as a barrier to immunotherapy in pancreatic adenocarcinoma
Challenges and Future Perspectives of Immunotherapy in Pancreatic Cancer
Attenuation of hedgehog/GLI signaling by NT1721 extends survival in pancreatic cancer
Chemokine CCL21 determines immunotherapy response in hepatocellular carcinoma by affecting neutrophil polarization
Neutrophil Camouflaged Stealth Nanovehicle for Photothermal‐Induced Tumor Immunotherapy by Triggering Pyroptosis
Clinical immunotherapy in pancreatic cancer
Role of Pancreatic Attenuation Index in Assessing Pancreatic Fat Content and Postpancreatectomy Outcomes
Barriers and opportunities in pancreatic cancer immunotherapy
Lipocalin-2 and neutrophil activation in pancreatic cancer cachexia
Neutrophil to lymphocyte ratio predicts prognosis in unresectable pancreatic cancer
Acquired resistance to immunotherapy in MMR-D pancreatic cancer
RNAi-Mediated PD-L1 Inhibition for Pancreatic Cancer Immunotherapy
Hypoxia as a barrier to immunotherapy in pancreatic adenocarcinoma
Challenges and Future Perspectives of Immunotherapy in Pancreatic Cancer
Attenuation of hedgehog/GLI signaling by NT1721 extends survival in pancreatic cancer
Chemokine CCL21 determines immunotherapy response in hepatocellular carcinoma by affecting neutrophil polarization